Jeffrey Vacirca

Track

Insider profile

Currently holds a position at Spectrum Pharmaceuticals Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Spectrum Pharmaceuticals Inc Nov. 9, 2018 -
Jeffrey Vacirca's trades of Caris Life Sciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
156.95
Quantity 49,926 +46.6%
Value US$544,767
Transaction date
Purchase
Price
26.00
Quantity 19,231 +480.8%
Value US$500,006
Transaction date
Purchase
Price
17.00
Quantity 1,000 +33.3%
Value US$17,000
Transaction date
Purchase
Price
17.00
Quantity 2,000 +200.0%
Value US$34,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-12 2026-05-11
B Purchase
36,649 -25.8%
117.10
US$3,519,150 		36,649 -25.8% 117.10 US$3,519,150
2024-06-12 2024-06-11
B Purchase
49,926 +46.6%
156.95
US$544,767 		49,926 +46.6% 156.95 US$544,767
2022-12-02 2022-11-30
B Purchase
73,078 +3.9%
396.56
US$4,003,685 		73,078 +3.9% 396.56 US$4,003,685
2019-06-28 2019-06-26
B Purchase
19,231 +480.8%
26.00
US$500,006 		19,231 +480.8% 26.00 US$500,006
2019-03-07 2019-03-04
B Purchase
1,000 +33.3%
17.00
US$17,000 		1,000 +33.3% 17.00 US$17,000
2019-03-07 2019-03-04
B Purchase
2,000 +200.0%
17.00
US$34,000 		2,000 +200.0% 17.00 US$34,000